Target intelligence / Profile preview

C-C motif chemokine ligand 27 (CCL27)

Target
CCL27
Molecular classification
Chemokine, Cytokine, Ligand (for G protein-coupled receptor CCR10), CC chemokine family member
01

Overview

C-C motif chemokine ligand 27 (CCL27), also known as cutaneous T cell-attracting chemokine (CTACK), is a small cytokine belonging to the CC chemokine family. It is primarily expressed by keratinocytes in the epidermis and functions as a potent chemoattractant for skin-homing memory T lymphocytes that express the receptor CCR10. CCL27 plays an essential role in mediating immune surveillance of the skin under normal conditions, but its expression is upregulated during inflammation by pro-inflammatory cytokines such as TNF-alpha and IL‑1β. Elevated serum levels of CCL27 are associated with inflammatory skin diseases including atopic dermatitis and psoriasis, where it correlates with disease severity. The molecule acts through binding to its main receptor CCR10, facilitating targeted migration of CLA+ memory T cells into inflamed or damaged cutaneous tissue. Its unique oligomerization properties may contribute to diverse interactions with glycosaminoglycans on cell surfaces, further modulating its function during immune responses.[1][2][3][4][5][6]

Other names
Cutaneous T cell-attracting chemokineCTACKESkineILC[5][6]
02

Biological functions

Chemotaxis of skin-homing memory T lymphocytesImmune response regulation in the skinLymphocyte homing to cutaneous sitesInflammatory signaling in skin diseases
03

Disease associations

Inflammation (notably atopic dermatitis and psoriasis)Autoimmune disease (cutaneous inflammation, graft-versus-host disease)
04

Biomarkers

Serum CCL27 levels as a biomarker for atopic dermatitis and psoriasis activity/severity

Beyond the preview

Go deeper on C-C motif chemokine ligand 27 (CCL27).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on C-C motif chemokine ligand 27 (CCL27).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call